A vaccine with Aβ oligomer-specific mimotope attenuates cognitive deficits and brain pathologies in transgenic mice with Alzheimer’s disease

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1758-9193

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: A vaccine with Aβ oligomer-specific mimotope attenuates cognitive deficits and brain pathologies in transgenic mice with Alzheimer’s disease ; volume:9 ; number:1 ; day:7 ; month:6 ; year:2017 ; pages:1-14 ; date:12.2017
Alzheimer's research & therapy ; 9, Heft 1 (7.6.2017), 1-14, 12.2017

Creator: Wang, Shao-Wei

Contributor: Liu, Dong-qun
Zhang, Ling-xiao
Ji, Mei
Zhang, Yang-xin
Dong, Quan-xiu
Liu, Shu-Ying
Xie, Xi-xiu
Liu, Rui-tian
SpringerLink (Online service)

DOI: 10.1186/s13195-017-0267-5

URN: urn:nbn:de:1111-201710182605

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:36 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Wang, Shao-Wei
Liu, Dong-qun
Zhang, Ling-xiao
Ji, Mei
Zhang, Yang-xin
Dong, Quan-xiu
Liu, Shu-Ying
Xie, Xi-xiu
Liu, Rui-tian
SpringerLink (Online service)

Other Objects (12)

Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer’s Mice with Full-blown Pathology

Associations of thyroid hormone serum levels with in-vivo Alzheimer’s disease pathologies

Interpretable classification of Alzheimer’s disease pathologies with a convolutional neural network pipeline

Proteomic changes in Alzheimer’s disease associated with progressive Aβ plaque and tau tangle pathologies

Plasma oligomer beta-amyloid is associated with disease severity and cerebral amyloid deposition in Alzheimer’s disease spectrum

Management of oxidative stress and other pathologies in Alzheimer’s disease

Distinguishing neurocognitive deficits in adult patients with NP-C from early onset Alzheimer’s dementia

Interleukin-1 mediates Alzheimer and Lewy body pathologies

Predicting probable Alzheimer’s disease using linguistic deficits and biomarkers

Aβ42 oligomer-specific antibody ALZ-201 reduces the neurotoxicity of Alzheimer’s disease brain extracts

Aβ/tau oligomer interplay at human synapses supports shifting therapeutic targets for Alzheimer’s disease

Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer’s Mice with Full-blown Pathology

Associations of thyroid hormone serum levels with in-vivo Alzheimer’s disease pathologies

Interpretable classification of Alzheimer’s disease pathologies with a convolutional neural network pipeline

Proteomic changes in Alzheimer’s disease associated with progressive Aβ plaque and tau tangle pathologies

Plasma oligomer beta-amyloid is associated with disease severity and cerebral amyloid deposition in Alzheimer’s disease spectrum

Management of oxidative stress and other pathologies in Alzheimer’s disease

Distinguishing neurocognitive deficits in adult patients with NP-C from early onset Alzheimer’s dementia

Interleukin-1 mediates Alzheimer and Lewy body pathologies

Predicting probable Alzheimer’s disease using linguistic deficits and biomarkers

Aβ42 oligomer-specific antibody ALZ-201 reduces the neurotoxicity of Alzheimer’s disease brain extracts

Aβ/tau oligomer interplay at human synapses supports shifting therapeutic targets for Alzheimer’s disease

Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer’s Mice with Full-blown Pathology

Associations of thyroid hormone serum levels with in-vivo Alzheimer’s disease pathologies

Interpretable classification of Alzheimer’s disease pathologies with a convolutional neural network pipeline

Proteomic changes in Alzheimer’s disease associated with progressive Aβ plaque and tau tangle pathologies

Plasma oligomer beta-amyloid is associated with disease severity and cerebral amyloid deposition in Alzheimer’s disease spectrum

Management of oxidative stress and other pathologies in Alzheimer’s disease

Distinguishing neurocognitive deficits in adult patients with NP-C from early onset Alzheimer’s dementia

Interleukin-1 mediates Alzheimer and Lewy body pathologies

Predicting probable Alzheimer’s disease using linguistic deficits and biomarkers

Aβ42 oligomer-specific antibody ALZ-201 reduces the neurotoxicity of Alzheimer’s disease brain extracts

Aβ/tau oligomer interplay at human synapses supports shifting therapeutic targets for Alzheimer’s disease

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

A vaccine with Aβ oligomer-specific mimotope attenuates cognitive deficits and brain pathologies in transgenic mice with Alzheimer’s disease

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer’s Mice with Full-blown Pathology

Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer’s Mice with Full-blown Pathology

Associations of thyroid hormone serum levels with in-vivo Alzheimer’s disease pathologies

Interpretable classification of Alzheimer’s disease pathologies with a convolutional neural network pipeline

Proteomic changes in Alzheimer’s disease associated with progressive Aβ plaque and tau tangle pathologies

Plasma oligomer beta-amyloid is associated with disease severity and cerebral amyloid deposition in Alzheimer’s disease spectrum

Management of oxidative stress and other pathologies in Alzheimer’s disease

Distinguishing neurocognitive deficits in adult patients with NP-C from early onset Alzheimer’s dementia

Interleukin-1 mediates Alzheimer and Lewy body pathologies

Predicting probable Alzheimer’s disease using linguistic deficits and biomarkers

Aβ42 oligomer-specific antibody ALZ-201 reduces the neurotoxicity of Alzheimer’s disease brain extracts

Aβ/tau oligomer interplay at human synapses supports shifting therapeutic targets for Alzheimer’s disease

Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer’s Mice with Full-blown Pathology

Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer’s Mice with Full-blown Pathology

Associations of thyroid hormone serum levels with in-vivo Alzheimer’s disease pathologies

Interpretable classification of Alzheimer’s disease pathologies with a convolutional neural network pipeline

Proteomic changes in Alzheimer’s disease associated with progressive Aβ plaque and tau tangle pathologies

Plasma oligomer beta-amyloid is associated with disease severity and cerebral amyloid deposition in Alzheimer’s disease spectrum

Management of oxidative stress and other pathologies in Alzheimer’s disease

Distinguishing neurocognitive deficits in adult patients with NP-C from early onset Alzheimer’s dementia

Interleukin-1 mediates Alzheimer and Lewy body pathologies

Predicting probable Alzheimer’s disease using linguistic deficits and biomarkers

Aβ42 oligomer-specific antibody ALZ-201 reduces the neurotoxicity of Alzheimer’s disease brain extracts

Aβ/tau oligomer interplay at human synapses supports shifting therapeutic targets for Alzheimer’s disease

Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer’s Mice with Full-blown Pathology

Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer’s Mice with Full-blown Pathology

Associations of thyroid hormone serum levels with in-vivo Alzheimer’s disease pathologies

Interpretable classification of Alzheimer’s disease pathologies with a convolutional neural network pipeline

Proteomic changes in Alzheimer’s disease associated with progressive Aβ plaque and tau tangle pathologies

Plasma oligomer beta-amyloid is associated with disease severity and cerebral amyloid deposition in Alzheimer’s disease spectrum

Management of oxidative stress and other pathologies in Alzheimer’s disease

Distinguishing neurocognitive deficits in adult patients with NP-C from early onset Alzheimer’s dementia

Interleukin-1 mediates Alzheimer and Lewy body pathologies

Predicting probable Alzheimer’s disease using linguistic deficits and biomarkers

Aβ42 oligomer-specific antibody ALZ-201 reduces the neurotoxicity of Alzheimer’s disease brain extracts

Aβ/tau oligomer interplay at human synapses supports shifting therapeutic targets for Alzheimer’s disease

Related objects

Reset password